PHARMACEUTICAL DISTRIBUTION SECURITY ALLIANCE

Lobbying Spend

—

Filings

Firms Hired

Active Period

2011–2014

Lobbying Spend by Year

Client-reported lobbying expenses on LDA filings

Year	Lobbying Spend	Filings	Firms
2014	—	6	1
2013	—	4	1
2012	—	5	1
2011	—	2	1

Lobbying firms retained by this client; amounts are client-reported expenses when available

Firm Name	Reported Spend	Filings
FAEGRE BAKER DANIELS CONSULTING	—	17

Government entities explicitly identified as targets in LDA filings

Government Body	Filings
HOUSE OF REPRESENTATIVES	16
SENATE	16
Food & Drug Administration (FDA)	15

Most frequently reported lobbying issues

Issue Code	Description	Reports
Health Issues	Health Issues	17

PHARMACEUTICAL DISTRIBUTION SECURITY ALLIANCE — Lobbying Disclosure | Poliscope